drugset
drugset / Trial / NCT07026110

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer

NCT07026110 ↗

Recruiting 100 enrolled RenJi Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This study aims to explore the efficacy of Trop2, EpCAM-specific PET/CT imaging for noninvasive visualization of Trop2 or EpCAM expression levels in non-small cell lung cancer; and to explore the differences between novel target-specific PET/CT examinations and conventional 18F-FDG PET/CT in the diagnosis and differential diagnosis of solid lung nodules.

Timeline

Start
2024-12-23
Primary completion
2026-10-31
Completion
2026-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]F-RESCA-EPCD6 Unknown 0.05 unknown Other
Subject [18F]F-RESCA-EPCD6 Unknown 0.1 unknown Other
Subject [18F]F-RESCA-RT4 Unknown 0.05 unknown Other
Subject [18F]F-RESCA-RT4 Unknown 0.1 unknown Other
Subject [18F]F-RESCA-T4 Unknown 0.05 unknown Other
Subject [18F]F-RESCA-T4 Unknown 0.1 unknown Other
Subject [68Ga]Ga-NOTA-EPCD6 Unknown 0.05 unknown Other
Subject [68Ga]Ga-NOTA-EPCD6 Unknown 0.1 unknown Other
Subject [68Ga]Ga-NOTA-RT4 Unknown 0.05 unknown Other
Subject [68Ga]Ga-NOTA-RT4 Unknown 0.1 unknown Other
Subject [68Ga]Ga-NOTA-T4 Unknown 0.05 unknown Other
Subject [68Ga]Ga-NOTA-T4 Unknown 0.1 unknown Other

Indications

lung cancer